Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 6609 - 6616 of 12008 results
“The cold never bothered me anyway!” SEC again uses its power to freeze an alleged EB-5 scam
October 11, 2017| Blog| Viewpoint
CMS Completes Final Medicare Part D Reconciliation for 2016
October 11, 2017| Blog| Viewpoint
What To Know About Boston's Status As A 'Sanctuary City'
October 11, 2017| News
U.S. Visa Processing in Turkey Suspended Amid Security Concerns; Turkey Responds in Kind
October 10, 2017| Alert| Viewpoint
OTC Drug Manufacturers: Keep Your Eyes and Ears on Congress
October 10, 2017| Blog| Viewpoint
Building a Health App? Part 4: Avoiding an FTC Enforcement Action
October 10, 2017| Blog| Viewpoint
Department of Veterans Affairs Aims to Trump State Telemedicine Rules
October 10, 2017| Blog| Viewpoint
Health Care Weekly Preview from ML Strategies – Week of October 9, 2017
October 10, 2017| Blog| Viewpoint
News & Press Releases
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Mintz’s Life Sciences practice has been shortlisted in multiple categories for the 2025 LMG Life Sciences Americas Awards. The winners will be announced at an awards ceremony in New York on September 4. In the United States, Mintz was shortlisted in the “Venture Capital Firm of the Year” category. In Canada, Mintz was shortlisted in the “Financial & Corporate Firm of the Year” and “Patent Strategy Firm of the Year” categories.
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Events
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|